Pharmaceutical company Merck & Co. said Monday it agreed to pay an eye-popping $1.1 billion to buy Sirna Therapeutics Inc., a tiny biotechnology firm developing drugs based on new technology at the heart of last month’s Nobel Prize for medicine award.
*For more on this story,
read the full AP article.
